Section of Hygiene, University Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Roma, Italia.
Faculty of Economics, Università Cattolica del Sacro Cuore, Rome, Italy.
BMC Public Health. 2024 Feb 14;24(1):464. doi: 10.1186/s12889-024-18009-8.
The advent of Personalized Medicine (PM) holds significant promise in revolutionizing healthcare by tailoring treatments to individual patients based on their data. However, its successful implementation requires the seamless integration of innovative technologies and presents formidable challenges in terms of sustainability. To tackle these challenges head-on, the International Consortium for Personalized Medicine (ICPerMed) was established, and the IC2PerMed project, as part of this consortium, seeks to foster collaboration between the European Union (EU) and China in the field of Personalized Medicine. Based on the results collected by the project, the objective of this study is to discern the key priorities for the implementation of Personalised Medicine concerning Information and Communication Technologies (ICT) and Big Data and digital solutions, with a particular emphasis on data management and protection.
A Delphi survey was conducted to gather expert's consensus on the main priorities for actions on Information and Communication Technologies (ICT) and Big Data and digital solutions in the field of Personalized Medicine.
The survey identified seven priorities in the area of Big Data and digital solutions, including data interoperability, standards, security measures, and international partnerships. Additionally, twelve priorities were identified for the innovation-to-market process, emphasizing cost-effectiveness, need assessment, and value definition in resource allocation.
The effective implementation of new technologies in Personalized Medicine research and practice is essential for the advancement of healthcare systems in both the European and Chinese contexts. The identified priorities play a pivotal role in promoting the sustainability of health systems and driving innovation in the implementation of Personalized Medicine. Addressing challenges related to data interoperability, standards, security, international collaboration, cost-effectiveness, and value assessment is of utmost importance in order to propel the progress of Personalized Medicine in healthcare systems.
个性化医疗(PM)的出现有望通过根据患者数据为个体患者量身定制治疗方案来彻底改变医疗保健。然而,其成功实施需要创新技术的无缝集成,并在可持续性方面带来巨大挑战。为了直面这些挑战,国际个性化医学联合会(ICPerMed)成立了,而作为该联合会一部分的 IC2PerMed 项目旨在促进欧盟(EU)和中国在个性化医学领域的合作。基于该项目收集的结果,本研究旨在确定在信息和通信技术(ICT)和大数据以及数字解决方案方面实施个性化医学的关键优先事项,特别强调数据管理和保护。
采用德尔菲法调查,就信息和通信技术(ICT)和大数据以及数字解决方案在个性化医学领域的主要行动优先事项征求专家意见。
该调查确定了大数据和数字解决方案领域的七个优先事项,包括数据互操作性、标准、安全措施和国际伙伴关系。此外,还确定了创新到市场流程的十二个优先事项,强调了成本效益、需求评估和资源分配中的价值定义。
在个性化医学研究和实践中有效实施新技术对于推进中西方医疗保健系统的发展至关重要。确定的优先事项在促进医疗保健系统的可持续性和推动个性化医学实施的创新方面发挥着关键作用。解决数据互操作性、标准、安全、国际合作、成本效益和价值评估方面的挑战对于推动医疗保健系统中个性化医学的进展至关重要。